sellas life sciences stock
Why SELLAS Life Sciences Is Surging Today. SELLAS Life Sciences Group has a.
The company has a market cap of 334 billion a PE ratio of 1822 and a beta of 093.

. The stock has a 50 day simple moving average of 9878 and a. SELLAS Life Sciences Group Inc NASDAQ. SLS announced topline data from its Phase 12 trial of galinpepimut-S GPS in WT1 relapsed or refractory platinum-resistant advanced metastatic ovarian.
Shares of FN stock opened at 9074 on Friday. 8 Things to Know About SELLAS Life Sciences as It Enjoys Reddit Bump Feb. 3 2021 at 1214 pm.
Related
1 day agoAddex Therapeutics presently has a consensus target price of 1500 suggesting a potential upside of 31783.
New Post Fda Grants Fast Track Designation To Galinpepimut S For Treating Multiple Myeloma Https Immuno Oncologynews Com Multiple Myeloma Fast Track Myeloma